Video | 15 February 2020 The Big Pharma double dip explained 1 min RESEARCH AND DEVELOPMENT Did you know that Big Pharma is making us pay twice for many of the medicines we buy? In this video we break down the numbers. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photograph by Bithin Das Press release Press release | 06 March 2018 Research and development MSF welcomes Members of the European Parliament response to the US pharmaceutical pressure to stop EU action on high drug prices Photograph by Anna Surinyach Topic overview Topic overview Research and development "We’re fighting a forest fire with spray bottles" Statement | 24 January 2018 Intellectual property and trade Research and development 142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property Photograph by Sami Siva Press release Press release | 03 August 2017 Intellectual property and trade Research and development Congress fails to boost treatment for neglected diseases 3 min Photograph by Matthew Smeal Press release Press release | 07 June 2017 Research and development US Congressional Committee advances legislation that fails to fix FDA PRV program for neglected diseases Statement | 07 March 2017 Research and development MSF statement at Human Rights Council panel discussion 4 min Photograph by Javeed Shah Press release Press release | 02 March 2017 Research and development United States of America US Lawmakers fail to fix flawed PRV program intended to promote new medicines for neglected diseases 3 min Photograph by Gwenn Dubourthoumieu Press release Press release | 02 February 2017 Research and development European public health advocates demand greater public returns from European Commission’s Research and Development Programme, Horizon 2020 3 min Load More
Photograph by Bithin Das Press release Press release | 06 March 2018 Research and development MSF welcomes Members of the European Parliament response to the US pharmaceutical pressure to stop EU action on high drug prices
Photograph by Anna Surinyach Topic overview Topic overview Research and development "We’re fighting a forest fire with spray bottles"
Statement | 24 January 2018 Intellectual property and trade Research and development 142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property
Photograph by Sami Siva Press release Press release | 03 August 2017 Intellectual property and trade Research and development Congress fails to boost treatment for neglected diseases 3 min
Photograph by Matthew Smeal Press release Press release | 07 June 2017 Research and development US Congressional Committee advances legislation that fails to fix FDA PRV program for neglected diseases
Statement | 07 March 2017 Research and development MSF statement at Human Rights Council panel discussion 4 min
Photograph by Javeed Shah Press release Press release | 02 March 2017 Research and development United States of America US Lawmakers fail to fix flawed PRV program intended to promote new medicines for neglected diseases 3 min
Photograph by Gwenn Dubourthoumieu Press release Press release | 02 February 2017 Research and development European public health advocates demand greater public returns from European Commission’s Research and Development Programme, Horizon 2020 3 min
